Integrated teams, data visualization, and full-service coordination between clinical, regulatory, and commercial functions can accelerate decision-making and development speed.
Ben Edwards, Chief Operating Officer at Avance Clinical, discussed common challenges in biotech in a recent video interview with Applied Clinical Trials.
He emphasized the importance of addressing preclinical package gaps to avoid delays and the need for CROs with deep scientific capabilities to create a sound scientific argument for new drugs.
Edwards also stressed the importance of obtaining patient data early to inform decision-making in the current funding climate, and noted the shift towards adaptive trial designs and the benefits of staying with the same CRO for continuity.
Effective coordination across functions requires integrated teams and data visualization, according to Edwards.
Author's summary: Collaboration accelerates drug development.